U
Ulrika L. Fagerberg
Researcher at Karolinska Institutet
Publications - 26
Citations - 2268
Ulrika L. Fagerberg is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 15, co-authored 25 publications receiving 1793 citations. Previous affiliations of Ulrika L. Fagerberg include Uppsala University & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.
Frank M. Ruemmele,Frank M. Ruemmele,Frank M. Ruemmele,Gábor Veres,Kaija-Leena Kolho,Anne Griffiths,Arie Levine,Johanna C. Escher,J. Amil Dias,Arrigo Barabino,Christian Braegger,Jiri Bronsky,Stephan Buderus,Javier Martín-de-Carpi,L. de Ridder,Ulrika L. Fagerberg,Jean-Pierre Hugot,Jaroslaw Kierkus,Sanja Kolaček,Sibylle Koletzko,Paolo Lionetti,Erasmo Miele,V.M. Navas Lopez,Anders Paerregaard,Richard K Russell,Daniela Elena Serban,Ron Shaoul,P. van Rheenen,Gigi Veereman,B Weiss,David Wilson,Axel Dignass,A Eliakim,Harland S. Winter,Dan Turner +34 more
TL;DR: These guidelines are intended to give practical (whenever possible evidence-based) answers to (pediatric) gastroenterologists who take care of children and adolescents with CD, since many different clinical scenario exist requiring treatment strategies not covered by or different from these guidelines.
Journal ArticleDOI
Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines
Dan Turner,Arie Levine,Johanna C. Escher,Anne M. Griffiths,Richard K. Russell,Axel Dignass,Jorge Amil Dias,Jiri Bronsky,Christian Braegger,Salvatore Cucchiara,Lissy de Ridder,Ulrika L. Fagerberg,Seamus Hussey,Jean-Pierre Hugot,Sanja Kolaček,Kaija-Leena Kolho,Paolo Lionetti,Anders Paerregaard,Alexander Potapov,Risto Rintala,Daniela Elena Serban,Annamaria Staiano,Brian Sweeny,Gigi Veerman,Gábor Veres,David C. Wilson,Frank M. Ruemmele +26 more
TL;DR: These guidelines provide clinically useful points to guide the management of UC in children and offer a standardized protocol that allows effective, timely management and monitoring of the disease course, while acknowledging that each patient is unique.
Journal ArticleDOI
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.
Patrick F. van Rheenen,Marina Aloi,Amit Assa,Jiri Bronsky,Johanna C. Escher,Ulrika L. Fagerberg,Marco Gasparetto,Konstantinos Gerasimidis,Anne M. Griffiths,Paul Henderson,Sibylle Koletzko,Sibylle Koletzko,Kaija-Leena Kolho,Arie Levine,Johan Van Limbergen,Francisco Javier Martin de Carpi,Víctor Manuel Navas-López,Salvatore Oliva,Lissy de Ridder,Richard K Russell,Dror S. Shouval,Dror S. Shouval,Antonino Spinelli,Dan Turner,David C. Wilson,Eytan Wine,Frank M. Ruemmele,Frank M. Ruemmele +27 more
TL;DR: An evidence-supported update of the ECCO-ESPGHAN guideline on the medical management of paediatric Crohn's disease is provided, establishing that it was key to identify patients at high risk of a complicated disease course at the earliest opportunity to reduce bowel damage.
Journal ArticleDOI
Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
TL;DR: Fecal calprotectin can be used to select patients who should undergo diagnostic colonoscopy for investigation of colorectal inflammation, including inflammatory bowel disease.
Journal ArticleDOI
Fecal calprotectin levels in healthy children studied with an improved assay
TL;DR: The suggested cutoff level for adults (<50 &mgr;g/g) can be used for children aged from 4 to 17 years regardless of sex, and the remaining 13 children with a calprotectin concentration >50 & mgr; g/g warrants follow-up.